Tenpoint Therapeutics

Developer of engineered cell-based therapeutics to restore vision

placeSeattle, Washington, United States calendar_todayFounded 2020 groups14 employees language tenpointtherapeutics.com

Registered entities

Investor mix

22 investors on record; lead investors include British Patient Capital, F-Prime Capital, Sofinnova Partners, EQT.

Investor typeCountShare
Venture capital836%
Private equity29%
Bank & private debt314%
Other / undisclosed941%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

18 Nov 2024 · CEO Assistant & Office Manager (100%) · Allschwil

Based on job postings tracked across public sources.

Coming soon